National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)



Prof. Ruben G. Carbonell, Director of BTEC, is one of the leaders in the establishment of NIIMBL, an institute that is part of the Manufacturing USA Network to enhance the nation’s manufacturing-based economy. NIIMBL’s mission is to advance the economic competitiveness of the US biopharmaceutical industry, to create jobs and improve the economy by accelerating the development and implementation of high-impact biomanufacturing innovations that can be applied to current and future biopharmaceutical products, and to educate and train a world-leading workforce for the future of this industry. NIIMBL was formally established on March 1, 2017, by a $70M collaborative agreement over five years from the National Institute for Standards and Technology (NIST), an institute that is part of the Department of Commerce.

The initial phase of NIIMBL began in early Spring 2017 with funding by the National Institute of Standards and Technology (NIST).  The first year of Institute activity saw a large number of accomplishments, including identification of Institute leadership, attraction of a diverse membership of academic institutions, non-profits and industry (current members include four Tier 1 companies, 29 academic institutions, 30 Tier 3 companies, and 16 non-profits and community colleges), development of technical and workforce roadmaps, and three calls for proposals from Institute members.  Each of these accomplishments have led to substantive benefits to academic and corporate interests in the State that are anticipated to have a major impact on biopharmaceutical manufacturing in North Carolina.

Learn more about funding opportunities